A tumor control probability model for anal squamous cell carcinoma
<p><strong>Background and purpose</strong> A recent update of the RTOG 9811, reported differing relapse rates for early and late anal squamous cell carcinoma following chemoradiotherapy (CRT). There may be a role for dose-individualization, however the dose–response relationship fo...
Auteurs principaux: | Muirhead, R, Partridge, M, Hawkins, M |
---|---|
Format: | Journal article |
Publié: |
Elsevier
2015
|
Documents similaires
-
WE-AB-202-10: Modelling individual tumor-specific control probability for hypoxia in rectal cancer.
par: Warren, S, et autres
Publié: (2016) -
Is there a role for a biological boost in squamous cell anal cancer?
par: Sabbagh, A, et autres
Publié: (2018) -
Is there a role for an FDG derived biological boost in squamous cell anal cancer?
par: Sabbagh, A, et autres
Publié: (2018) -
Oxygen-enhanced MRI MOLLI T1 mapping during chemoradiotherapy in anal squamous cell carcinoma
par: Bluemke, E, et autres
Publié: (2020) -
Anal Intraepithelial Neoplasia: Precursor of Anal Squamous Cell Carcinoma
par: Taku Sakamoto, et autres
Publié: (2022-04-01)